BMO Capital initiates coverage on Ra Pharma (NASDAQ: RARX) with a Outperform rating and a price target of $20.00.Analyst Matt ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE